Evidence map›Paper›PMID 35366472›Full record

ArticleComputers in biology and medicine2022

A bioinformatic approach of targeting SARS-CoV-2 replication by silencing a conserved alternative reserve of the orf8 gene using host miRNAs.

Vaggu Raghavendra Goud, Rajasree Chakraborty, Averi Chakraborty, Kousalya Lavudi, Sriram Patnaik, Swati Sharma, Srinivas Patnaik

Abstract read
In one paragraph

Article in Computers in biology and medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vaggu Raghavendra GoudSchool of Biotechnology, KIIT University, Bhubaneswar, India.
Rajasree ChakrabortySchool of Biotechnology, KIIT University, Bhubaneswar, India.
Averi ChakrabortySchool of Biotechnology, KIIT University, Bhubaneswar, India.
Kousalya LavudiSchool of Biotechnology, KIIT University, Bhubaneswar, India.
Sriram PatnaikSchool of Biotechnology, KIIT University, Bhubaneswar, India.
Swati SharmaSchool of Biotechnology, KIIT University, Bhubaneswar, India; Dept. of Skill Buildings Shri Ramasamy Memorial University, Sikkim, Gangtok, 737102, India.
Srinivas PatnaikSchool of Biotechnology, KIIT University, Bhubaneswar, India. Electronic address: srinivas.patnaik@kiitbiotech.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The causative agent of the COVID-19 pandemic, the SARS-CoV-2 virus has yielded multiple relevant mutations, many of which have branched into major variants. The Omicron variant has a huge similarity with the original viral strain (first COVID-19 strain from Wuhan). Among different genes, the highly variable orf8 gene is responsible for crucial host interactions and has undergone multiple mutations and indels. The sequence of the orf8 gene of the Omicron variant is, however, identical with the gene sequence of the wild type. orf8 modulates the host immunity making it easier for the virus to conceal itself and remain undetected. Variants seem to be deleting this gene without affecting the viral replication. While analyzing, we came across the conserved orf7a gene in the viral genome which exhibits a partial sequence homology as well as functional similarity with the SARS-CoV-2 orf8. Hence, we have proposed here in our hypothesis that, orf7a might be an alternative reserve of orf8 present in the virus which was compensating for the lost gene. A computational approach was adopted where we screened various miRNAs targeted against the orf8 gene. These miRNAs were then docked onto the orf8 mRNA sequences. The same set of miRNAs was then used to check for their binding affinity with the orf7a reference mRNA. Results showed that miRNAs targeting the orf8 had favorable shape complementarity and successfully docked with the orf7a gene as well. These findings provide a basis for developing new therapeutic approaches where both orf8 and orf7a can be targeted simultaneously.

Indexed as

COVID-19MicroRNAsComputational BiologyHumansPandemicsRNA, MessengerSARS-CoV-2Viral ProteinsMicroRNAsRNA, MessengerViral ProteinsGene silencingmiRNAsMolecular dockingOmicronorf7aorf8SARS-CoV-2

Identifiers

PMID35366472
PMCPMC8942883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.